BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

538 related articles for article (PubMed ID: 33276499)

  • 21. The diversity and possible functions of the inositol polyphosphate 5-phosphatases.
    Erneux C; Govaerts C; Communi D; Pesesse X
    Biochim Biophys Acta; 1998 Dec; 1436(1-2):185-99. PubMed ID: 9838104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells.
    Choi Y; Zhang J; Murga C; Yu H; Koller E; Monia BP; Gutkind JS; Li W
    Oncogene; 2002 Aug; 21(34):5289-300. PubMed ID: 12149650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative mechanistic and substrate specificity study of inositol polyphosphate 5-phosphatase Schizosaccharomyces pombe Synaptojanin and SHIP2.
    Chi Y; Zhou B; Wang WQ; Chung SK; Kwon YU; Ahn YH; Chang YT; Tsujishita Y; Hurley JH; Zhang ZY
    J Biol Chem; 2004 Oct; 279(43):44987-95. PubMed ID: 15316017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SH2-containing inositol 5-phosphatases 1 and 2 in blood platelets: their interactions and roles in the control of phosphatidylinositol 3,4,5-trisphosphate levels.
    Giuriato S; Pesesse X; Bodin S; Sasaki T; Viala C; Marion E; Penninger J; Schurmans S; Erneux C; Payrastre B
    Biochem J; 2003 Nov; 376(Pt 1):199-207. PubMed ID: 12885297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of VPS34-IN1, a selective inhibitor of Vps34, reveals that the phosphatidylinositol 3-phosphate-binding SGK3 protein kinase is a downstream target of class III phosphoinositide 3-kinase.
    Bago R; Malik N; Munson MJ; Prescott AR; Davies P; Sommer E; Shpiro N; Ward R; Cross D; Ganley IG; Alessi DR
    Biochem J; 2014 Nov; 463(3):413-27. PubMed ID: 25177796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SHIP2 controls PtdIns(3,4,5)P(3) levels and PKB activity in response to oxidative stress.
    Zhang J; Liu Z; Rasschaert J; Blero D; Deneubourg L; Schurmans S; Erneux C; Pesesse X
    Cell Signal; 2007 Oct; 19(10):2194-200. PubMed ID: 17643961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The inositol polyphosphate 5-phosphatases: traffic controllers, waistline watchers and tumour suppressors?
    Astle MV; Horan KA; Ooms LM; Mitchell CA
    Biochem Soc Symp; 2007; (74):161-81. PubMed ID: 17233589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipid phosphatase SHIP2 functions as oncogene in colorectal cancer by regulating PKB activation.
    Hoekstra E; Das AM; Willemsen M; Swets M; Kuppen PJ; van der Woude CJ; Bruno MJ; Shah JP; Ten Hagen TL; Chisholm JD; Kerr WG; Peppelenbosch MP; Fuhler GM
    Oncotarget; 2016 Nov; 7(45):73525-73540. PubMed ID: 27716613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phosphoinositide lipid phosphatase SHIP1 and PTEN coordinate to regulate cell migration and adhesion.
    Mondal S; Subramanian KK; Sakai J; Bajrami B; Luo HR
    Mol Biol Cell; 2012 Apr; 23(7):1219-30. PubMed ID: 22323291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphatidylinositol 3,4,5-trisphosphate modulation in SHIP2-deficient mouse embryonic fibroblasts.
    Blero D; Zhang J; Pesesse X; Payrastre B; Dumont JE; Schurmans S; Erneux C
    FEBS J; 2005 May; 272(10):2512-22. PubMed ID: 15885100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inositol polyphosphate 4-phosphatase II regulates PI3K/Akt signaling and is lost in human basal-like breast cancers.
    Fedele CG; Ooms LM; Ho M; Vieusseux J; O'Toole SA; Millar EK; Lopez-Knowles E; Sriratana A; Gurung R; Baglietto L; Giles GG; Bailey CG; Rasko JE; Shields BJ; Price JT; Majerus PW; Sutherland RL; Tiganis T; McLean CA; Mitchell CA
    Proc Natl Acad Sci U S A; 2010 Dec; 107(51):22231-6. PubMed ID: 21127264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence that SHIP-1 contributes to phosphatidylinositol 3,4,5-trisphosphate metabolism in T lymphocytes and can regulate novel phosphoinositide 3-kinase effectors.
    Freeburn RW; Wright KL; Burgess SJ; Astoul E; Cantrell DA; Ward SG
    J Immunol; 2002 Nov; 169(10):5441-50. PubMed ID: 12421919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The control of phosphatidylinositol 3,4-bisphosphate concentrations by activation of the Src homology 2 domain containing inositol polyphosphate 5-phosphatase 2, SHIP2.
    Batty IH; van der Kaay J; Gray A; Telfer JF; Dixon MJ; Downes CP
    Biochem J; 2007 Oct; 407(2):255-66. PubMed ID: 17672824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Control of cell polarity and motility by the PtdIns(3,4,5)P3 phosphatase SHIP1.
    Nishio M; Watanabe K; Sasaki J; Taya C; Takasuga S; Iizuka R; Balla T; Yamazaki M; Watanabe H; Itoh R; Kuroda S; Horie Y; Förster I; Mak TW; Yonekawa H; Penninger JM; Kanaho Y; Suzuki A; Sasaki T
    Nat Cell Biol; 2007 Jan; 9(1):36-44. PubMed ID: 17173042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The termination of PI3K signalling by SHIP1 and SHIP2 inositol 5-phosphatases.
    Backers K; Blero D; Paternotte N; Zhang J; Erneux C
    Adv Enzyme Regul; 2003; 43():15-28. PubMed ID: 12791379
    [No Abstract]   [Full Text] [Related]  

  • 36. Regulation of phosphoinositide signaling by the inositol polyphosphate 5-phosphatases.
    Astle MV; Seaton G; Davies EM; Fedele CG; Rahman P; Arsala L; Mitchell CA
    IUBMB Life; 2006 Aug; 58(8):451-6. PubMed ID: 16916781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Silencer of death domains (SODD) inhibits skeletal muscle and kidney enriched inositol 5-phosphatase (SKIP) and regulates phosphoinositide 3-kinase (PI3K)/Akt signaling to the actin cytoskeleton.
    Rahman P; Huysmans RD; Wiradjaja F; Gurung R; Ooms LM; Sheffield DA; Dyson JM; Layton MJ; Sriratana A; Takada H; Tiganis T; Mitchell CA
    J Biol Chem; 2011 Aug; 286(34):29758-70. PubMed ID: 21712384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The SH2 domain containing inositol polyphosphate 5-phosphatase-2: SHIP2.
    Dyson JM; Kong AM; Wiradjaja F; Astle MV; Gurung R; Mitchell CA
    Int J Biochem Cell Biol; 2005 Nov; 37(11):2260-5. PubMed ID: 15964236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 5-Stabilized phosphatidylinositol 3,4,5-trisphosphate analogues bind Grp1 PH, inhibit phosphoinositide phosphatases, and block neutrophil migration.
    Zhang H; He J; Kutateladze TG; Sakai T; Sasaki T; Markadieu N; Erneux C; Prestwich GD
    Chembiochem; 2010 Feb; 11(3):388-95. PubMed ID: 20052709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of insulin signaling and glucose transporter 4 (GLUT4) exocytosis by phosphatidylinositol 3,4,5-trisphosphate (PIP3) phosphatase, skeletal muscle, and kidney enriched inositol polyphosphate phosphatase (SKIP).
    Ijuin T; Takenawa T
    J Biol Chem; 2012 Mar; 287(10):6991-9. PubMed ID: 22247557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.